Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. J Gastrointest Oncol. 2019 Aug;10(4):674-87. doi: 10.21037/jgo.2019.03.11
Clarkson TB, Anthony MS. Effects of SERMs, tibolone, and soy isoflavones on cardiovascular risk factors and coronary artery atherosclerosis of surgically post-menopausal monkeys. J Menopausal Med. 2001;10(1):19-23.